FOLH1 and prostate cancer: Çağlar et al., in their study with 95 newly diagnosed or recurrent prostate cancer patients, found a moderate positive correlation between the number of bone metastasic regions on Ga68-PSMA PET/CT and serum ALP levels (r = 0.697, p < 0.001) [16].